Health IssuesStrategic advice and counsel on issues impacting gene and cell therapy development and accessLobbied: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), Health & Human Services, Dept of (HHS), HOUSE OF REPRESENTATIVES, SENATE
Health IssuesStrategic advice and counsel on issues impacting gene and cell therapy development and accessLobbied: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), Health & Human Services, Dept of (HHS), HOUSE OF REPRESENTATIVES, SENATE
The report’s record: the firm and its client, the income or expenses, each issue with the report’s own words and the agencies lobbied, and every amendment.
Source: lda.gov, the Secretary of the Senate’s and the Clerk of the House’s Lobbying Disclosure Act reports, read . Senate Office of Public Records cannot vouch for the data or analyses derived from these data after the data have been retrieved from LDA.gov.